[1]
Amra ADROVIC et al. 2021. Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review. Archives of Rheumatology. 36, 1 (Mar. 2021), 146–157. DOI:https://doi.org/10.46497/ArchRheumatol.2021.7953.